InflaRx Looks Ahead To Late 2023 Commercial Sales For COVID-19 Antibody

Gohibic Cleared Under EUA

 
• By Alaric DeArment
  
InflaRx received an EUA from the FDA for Gohibic • Source: Shutterstock

More from New Products

More from Scrip